Session Details
[27-20-pm]Rational Use of Medicines, Pharmacotherapy (Basic Research)
Thu. Mar 27, 2025 3:10 PM - 4:46 PM JST
Thu. Mar 27, 2025 6:10 AM - 7:46 AM UTC
Thu. Mar 27, 2025 6:10 AM - 7:46 AM UTC
Room 20 (FUKUOKA SUNPALACE: Palace RoomB [2F])
Chair: Yoshito Zamami, Yoko Nawata
[27-20-pm09]Evaluation of the chelating ability of kampo formulations containing mineral-based crude drugs
○Kazuki Umemoto1, Yoko Urashima1, Tokio Obata1 (1. Pharm., Osaka Ohtani Univ.)
[27-20-pm10]Analysis of pharmaceutical inquiries by community pharmacists regarding the appropriate use of outpatient antiviral therapy.
○Sana Tsushima1, Rinoka Kadowaki1, Sana Tamura1, Masakazu Hirose1, Hirosi Takane1 (1. Fac. Pharm. & Pharmaceut. Sci., Fukuyama Univ.)
[27-20-pm11S]The role of epigenetic alterations in afatinib-induced gastrointestinal side effects
○Ippei Uemura1, Takashi Satoh2, Natsuko Suzuki2 (1. Grad. Sch. Pharm. Sci., Hokkaido Univ. of Sci., 2. Dept. of Pharm., Hokkaido Univ. of Sci.)
[27-20-pm12]Correlation analysis of superoxide generation in one microliter of blood and absolute neutrophil count in mice
○Misaki Matsumoto1, Honoka Onishi1, Mau Mukumoto1, Masashi Kakae1, Mitsunori Doi1, Takayuki Nakagawa1 (1. Sch. Pharm. Sci., Wakayama Med. Univ.)
[27-20-pm13S]Effects of taking the immunosuppressant drug azathioprine during pregnancy on the development of newborns.
○Yui Nakadai1, Hiromasa Kato1, Yuki Kawasaki1, Saya Matsumoto1, Yui Komatsu1, Wataru Ochiai1 (1. Hoshi Univ.)
[27-20-pm14]Effects of Porcine Liver Decomposition Product on behavior and immune system in a mouse model of LPS-induced inflammation
○Kiko Ishida1,2, Ikuya Sato1, Hisao Haniu3, Ken-ichi Sako1, Tomoji Maeda1, Tohru Takahashi1, Takahiro Kawase4, Takamitsu Tukahara4, Akio Hirai5, Kazusaburo Sato5, Yoshikazu Maeda1 (1. Nihon Pharamaceutical Univ., 2. Tachikawa hospital, 3. Biomedical Institu, 4. Kyoto Institute of Nutrition & Pathology, 5. Sugar Lady Cosmetics)
[27-20-pm15S]Exendin-4 enhanced α-Synuclein clearance in Blood-Brain Barrier constituting cell types.
○Miki Yokoya1, Junichi Matsumoto1, Junko Mizoguchi1, Fuyuko Takata1, Takuro Iwao1, Hisataka Aridome1, Kazunori Sano1, Shinya Dohgu1 (1. Fac. Pharmaceut. Sci., Fukuoka Univ.)
[27-20-pm16S]Esomeprazole prevents oxaliplatin-induced peripheral neuropathy by inhibition of organic cation transporter 2
○Manami Ueno1, Akihide Kobayashi2,3, Kenji Ikemura2,3, Eri Wakai4, Fumihiro Yamane1, Masahiro Okuda2,3 (1. Sch. Pharm. Sci., Osaka Univ., 2. Dept. Pharm., Osaka Univ. Hosp., 3. Grad. Sch. Med., Osaka Univ., 4. Sch. Pharm. Sci., Ritsumeikan Univ.)